Table 3.
The characteristics of studies included in the systematic review and meta-analysis.
| Study name | Event(n) | Total(n) | Prevalence (%) | Method | Country/Area |
|---|---|---|---|---|---|
| Olagunju 2012 (9) | 65 | 300 | 21.7 | ICD-10 | Lagos, Nigeria |
| Parhami 2013 (10) | 1264 | 7834 | 16.1 | ICD-9 | California. USA |
| Van Den Heuvel 2013 (11) | 285 | 418 | 68.2 | M.I.N.I.(DSM-IV) | Zambia |
| Leyro 2015 (12) | 64 | 139 | 46.0 | DSM-IV Axis I Disorders non-Participant Edition | San Francisco, USA |
| Levy 2019 (13) | 708 | 5904 | 12.0 | DSM-V | Washington DC, USA |
| Brown 2020 (14) | 225 | 37438 | 0.6 | ICD-9 | USA |
| Lang 2022 (15) | 34219 | 122896 | 27.8 | ICD-9/ICD-10 | USA |
| Liu 2022 (16) | 2016 | 63000 | 3.2 | DSM-V | China |
| Ong 2022 (17) | 82 | 191 | 42.9 | M.I.N.I.(DSM-III) | Malaya |
| Wanjala 2022 (18) | 24 | 450 | 5.3 | DSM-IV | Kenya |